You are here

Japan biotech venture PeptiDream a US$3b business

Tuesday, June 21, 2016 - 05:50

Mr Kubota (right) and Prof Suga, whose lab developed an artificial ribozyme, which he named flexizyme for its "promiscuous" ability to help amino acids couple to form peptides.


WHEN he realised he wasn't going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.

Many years spent fiddling with the building blocks of the universe - combining molecules to form compounds - led

Market voices on:

Pair your daily business read with the perfect cup of espresso.

Subscribe to The Business Times today to receive your very own Nespresso Inissia coffee machine worth $188.

Find out more at

Powered by GET.comGetCom